iRhythm Technologies, Inc. (IRTC) is a Healthcare stock trading at $104.41 (as of 2026-06-18), with a market capitalization of $3.74B and a trailing P/E of -128.0. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
iRhythm Technologies provides ambulatory electrocardiogram monitoring products in the United States, including the Zio service that uses a wire-free, patch-based wearable biosensor with a cloud-based analytics platform for physicians to monitor patients and help diagnose arrhythmias. Its Zio XT and AT monitors are single-use wearables, and the company also has a development collaboration with Verily Life Sciences for next-generation atrial fibrillation screening, detection, or monitoring offerings.